与铁亡相关的基因,是焦点细分质硬化症的新型治疗点
Yanbin Lin1, Jinxuan He1, Zhixiang Mou1
1Department of Nephrology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
BMC nephrology
|February 17, 2024
概括
这项研究确定了关键的与铁亡相关的基因 (FRG) 和涉及焦点细分结核硬化 (FSGS) 的转录分子. 这些发现为FSGS病提供了潜在的新诊断和治疗点.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 铁亡,一种受调节的细胞死亡,与脏疾病有关.
- 铁质在焦点细分结核硬化 (FSGS) 中的作用尚不清楚.
- 识别FSGS中的分子机制对于开发向疗法至关重要.
研究的目的:
- 为了研究铁死在FSGS中的作用.
- 在FSGS管样本中识别差异表达的铁亡相关基因 (FRG).
- 发现FSGS的潜在诊断和治疗目标.
主要方法:
- 对公共转录基因数据集 (GSE125779,GSE121211,GSE108112) 的分析.
- 鉴定差异表达基因 (DEGs) 和与铁亡相关的基因 (FRGs).
- 构建蛋白质-蛋白质相互作用网络,mRNA-miRNA网络,并预测circRNAs.
- 基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 途径分析.
主要成果:
- 在FSGS中确定了16种与铁死相关的DEG.
- 五个枢纽基因 (JUN,HIF1A,ALB,DUSP1,ATF3) 被确定为关键参与者.
- 凯格 (KEGG) 分析将FRG与线粒,细胞癌和代谢途径联系起来.
- 预测了新的mRNA-miRNA相互作用和潜在的药物标.
结论:
- 这项研究通过识别关键的枢纽FRG和转录基因分子来阐明ferroptosis在FSGS中的作用.
- 已识别的基因和分子代表FSGS的有希望的新型诊断和治疗标.
- 对这些目标的进一步研究可以推进FSGS治疗策略.
更多相关视频
06:39Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
5.6K
04:01Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
988
相关概念视频
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...